Histologic Lesions of Porto-Sinusoidal Vascular Disease Following Phlebotomy in Hemochromatosis
暂无分享,去创建一个
Deepa T. Patil | Hwajeong Lee | Chunlai Zuo | Kelsey E. McHugh | Brandon H. Koo | Sungeun Kim | Tony El Jabbour
[1] V. Vilgrain,et al. Porto-sinusoidal vascular disease: proposal and description of a novel entity. , 2019, The lancet. Gastroenterology & hepatology.
[2] P. Hytiroglou,et al. Regression of human cirrhosis: an update, 18 years after the pioneering article by Wanless et al. , 2018, Virchows Archiv.
[3] Hwajeong Lee,et al. Prevalence of histological features of idiopathic noncirrhotic portal hypertension in general population: a retrospective study of incidental liver biopsies , 2017, Hepatology International.
[4] C. Author,et al. Idiopathic Noncirrhotic Portal Hypertension: An Appraisal , 2015, Journal of pathology and translational medicine.
[5] C. Mulder,et al. Diagnosing Nodular Regenerative Hyperplasia of the Liver Is Thwarted by Low Interobserver Agreement , 2015, PloS one.
[6] C. Sheehan,et al. Histological Spectrum of Idiopathic Noncirrhotic Portal Hypertension in Liver Biopsies From Dialysis Patients , 2015, International journal of surgical pathology.
[7] N. Petrosillo,et al. Incomplete septal cirrhosis after high‐dose methylprednisolone therapy and regression of liver injury , 2015, Liver international : official journal of the International Association for the Study of the Liver.
[8] V. Ertekin,et al. Hepatoportal Sclerosis in Childhood: Descriptive Analysis of 12 Patients , 2013, Journal of Korean medical science.
[9] T. Schiano,et al. Obliterative Portal Venopathy: A Clinical and Histopathological Review , 2013, Digestive Diseases and Sciences.
[10] T. Roskams,et al. Histological features in western patients with idiopathic non‐cirrhotic portal hypertension , 2013, Histopathology.
[11] John F. Flaherty,et al. Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study , 2013, The Lancet.
[12] D. Valla,et al. Idiopathic noncirrhotic portal hypertension , 2011, Hepatology.
[13] V. Paradis,et al. Obliterative portal venopathy: portal hypertension is not always present at diagnosis. , 2011, Journal of hepatology.
[14] E. Schiff,et al. Long‐term entecavir therapy results in the reversal of fibrosis/cirrhosis and continued histological improvement in patients with chronic hepatitis B , 2010, Hepatology.
[15] S. Ben-Dor,et al. A Critical Role for Ceramide Synthase 2 in Liver Homeostasis , 2010, The Journal of Biological Chemistry.
[16] George Kitis,et al. Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B for up to 5 years. , 2006, Gastroenterology.
[17] P. Brissot,et al. Reversibility of hepatic fibrosis in treated genetic hemochromatosis: A study of 36 cases , 2006, Hepatology.
[18] N. Andrews,et al. Iron homeostasis and inherited iron overload disorders: an overview. , 2004, Hematology/oncology clinics of North America.
[19] L. A. D. de Freitas,et al. Incomplete septal cirrhosis: an enigmatic disease , 2004, Liver international : official journal of the International Association for the Study of the Liver.
[20] A. Czaja,et al. Decreased fibrosis during corticosteroid therapy of autoimmune hepatitis. , 2004, Journal of hepatology.
[21] F. Colina,et al. Clinicopathological features of nine cases of non‐cirrhotic portal hypertension: current definitions and criteria are inadequate , 2003, Histopathology.
[22] K. Tsuneyama,et al. Incomplete septal cirrhosis associated with Wegener's granulomatosis. , 2002, Liver.
[23] D. Valla,et al. Idiopathic non-cirrhotic intrahepatic portal hypertension in the West: a re-evaluation in 28 patients , 2002, Gut.
[24] M. Manns,et al. Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C. , 2002, Gastroenterology.
[25] M. Sherman,et al. Regression of human cirrhosis. Morphologic features and the genesis of incomplete septal cirrhosis. , 2000, Archives of pathology & laboratory medicine.
[26] T. Terada,et al. Histopathology of the liver in non‐cirrhotic portal hypertension of unknown aetiology , 1996, Histopathology.
[27] I. Wanless. micronodular transpormation (nodular regenerative hyperplasia) of the liver: A report of 64 cases among 2,500 autopsies and a new classification of benign hepatocellular nodules , 1990, Hepatology.
[28] R. Sciot,et al. Incomplete septal cirrhosis: histopathological aspects , 1988, Histopathology.
[29] E. Schiff,et al. Histological outcome during long-term lamivudine therapy. , 2003, Gastroenterology.
[30] I. Wanless,et al. Intrahepatic portal vein sclerosis in patients without a history of liver disease. An autopsy study. , 1982, The American journal of pathology.